首页> 外文期刊>Npj - Primary Care Respiratory Medicine >Hospital readmissions for COPD: a retrospective longitudinal study
【24h】

Hospital readmissions for COPD: a retrospective longitudinal study

机译:慢性阻塞性肺病住院入院:一项回顾性纵向研究

获取原文
           

摘要

Prevention of chronic obstructive pulmonary disease hospital readmissions is an international priority aimed to slow disease progression and limit costs. Evidence of the risk of readmission and of interventions that might prevent it is lacking. We aimed to determine readmission risk for chronic obstructive pulmonary disease, factors influencing that risk, and variation in readmission risk between hospitals across 7.5 million people in London. This retrospective longitudinal observational study included all chronic obstructive pulmonary disease admissions to any hospital in the United Kingdom among patients registered at London general practices who had emergency National Health Service chronic obstructive pulmonary disease hospital admissions between April 2006 and March 2010. Influence of patient characteristics, geographical deprivation score, length of stay, day of week of admission or of discharge, and admitting hospital, were assessed using multiple logistic regression. 38,894 chronic obstructive pulmonary disease admissions of 20,932 patients aged鈥夆墺鈥?5 years registered with London general practices were recorded. 6295 patients (32.2%) had at least one chronic obstructive pulmonary disease readmission within 1 year. 1993 patients (10.2%) were readmitted within 30 days and 3471 patients (17.8%) were readmitted within 90 days. Age and patient geographical deprivation score were very weak predictors of readmission. Rates of chronic obstructive pulmonary disease readmissions within 30 days and within 90 days did not vary among the majority of hospitals. The finding of lower chronic obstructive pulmonary disease readmission rates than was previously estimated and the limited variation in these rates between hospitals suggests that the opportunity to reduce chronic obstructive pulmonary disease readmission risk is small.
机译:预防慢性阻塞性肺疾病再次入院是国际优先事项,旨在减缓疾病进展并限制成本。缺乏再次入院风险和可能阻止再次入院的干预措施的证据。我们旨在确定慢性阻塞性肺疾病的再入院风险,影响该风险的因素以及伦敦750万人间医院之间的再入院风险的差异。这项回顾性纵向观察性研究包括2006年4月至2010年3月在伦敦全科就诊并急诊的National Health Service慢性阻塞性肺疾病住院患者在英国任何一家医院的所有慢性阻塞性肺疾病住院患者。使用多元Logistic回归评估地理剥夺评分,住院时间,入院或出院的星期几以及就诊医院。记录有20,932名5岁至5岁的伦敦一般医疗机构登记的38,894例慢性阻塞性肺疾病患者。 1295例患者中有6295例(32.2%)患有至少一种慢性阻塞性肺疾病。 1993例(10.2%)在30天内重新入院,3471例(17.8%)在90天内重新入院。年龄和患者的地理剥夺评分是再入院的非常弱的预测指标。大多数医院在30天内和90天内的慢性阻塞性肺疾病再入院率没有变化。慢性阻塞性肺病再入院率低于先前估计的发现,而且各医院之间这些比率的变化有限,这表明降低慢性阻塞性肺病再入院风险的机会很小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号